CrowdStrike's high valuation and modest guidance raise concerns despite its leadership in cybersecurity. Check out why I ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

EastGroup Properties has paid 182 straight quarterly dividends. Realty Income has raised its dividend payment for 110 ...

Named for the Roman goddess of love and fertility, Venus is the fine, divine feminine counterpart to aggro warlord Mars.

We recently published a list of Jim Cramer Talked About These 16 Stocks Recently. In this article, we are going to take a ...

YieldMax Ultra Option Income Strategy ETF offers high income via option premiums, but suffers from capital erosion and high ...

Stocks were mixed on Wednesday after a U.S. private-sector jobs report for May came in weaker than expected and the Federal ...

British billionaire investor Terry Smith is known as “the English Warren Buffett.” His London-based investment management ...

Apple Inc.'s stock has struggled to find positive momentum this year, and analysts at Needham & Company don't see major catalysts ahead that can help put shares on a better course.

As Americans begin to embark on their summer vacations, a new travel trend has people seeking “quaint” destinations.

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It's all about ...